Aug 20, 2026 07:16AM
Aug 18, 2026 09:00AM
Jul 31, 2026 04:48PM
Jul 29, 2026 06:14AM
Jun 25, 2026 07:28AM
Jun 25, 2026 07:28AM
Jun 24, 2026 06:23AM Leerink Starts Quince Therapeutics Inc. (QNCX) at Outperform
Jun 23, 2026 06:43AM
Mar 30, 2026 08:32AM
Feb 11, 2026 02:20PM
Jan 30, 2026 12:21PM
Jan 30, 2026 07:45AM
Jan 30, 2026 07:01AM
Jan 30, 2026 12:59AM Citizens Downgrades Quince Therapeutics Inc. (QNCX) to Market Perform
Jan 29, 2026 03:07PM
Jan 22, 2026 05:00AM
Jan 9, 2026 04:37AM
Jan 6, 2026 05:16AM
Dec 11, 2025 04:15AM
Dec 10, 2025 04:08PM
Nov 13, 2025 06:30AM Cortexyme, Inc. (QNCX) Misses Q3 EPS by 3c
Oct 9, 2025 04:07PM
Oct 3, 2025 04:10AM
Sep 26, 2025 04:23AM
Sep 25, 2025 04:05PM
Aug 12, 2025 04:18AM
Aug 5, 2025 02:35AM
Jul 15, 2025 07:44AM Lucid Capital Markets Starts Quince Therapeutics Inc. (QNCX) at Buy
Jul 10, 2025 04:05PM
Jun 12, 2025 05:15PM
May 13, 2025 05:25PM
Mar 25, 2025 07:11AM
Mar 24, 2025 06:03AM
Feb 4, 2025 04:06PM
Dec 18, 2024 04:07PM Quince Therapeutics (QNCX) Files $200M Mixed Shelf
Dec 18, 2024 04:05AM
Nov 13, 2024 04:26PM
Nov 12, 2024 04:05PM
Nov 11, 2024 04:05PM
Oct 29, 2024 06:48AM
Oct 22, 2024 07:18AM
Aug 15, 2024 07:01AM Quince Therapeutics (QNCX) Announces The Lancet Neurology Publication of Phase 3 ATTeST Trial of EryDex
Aug 13, 2024 05:56PM

448,257 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All